JNBA Financial Advisors cut its holdings in UnitedHealth Group Inc (NYSE:UNH) by 75.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 450 shares of the healthcare conglomerate’s stock after selling 1,364 shares during the period. JNBA Financial Advisors’ holdings in UnitedHealth Group were worth $120,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. White Lighthouse Investment Management Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $324,000. Wells Fargo & Company MN lifted its holdings in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after acquiring an additional 39,480 shares during the last quarter. Sawtooth Solutions LLC lifted its holdings in shares of UnitedHealth Group by 34.4% during the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after acquiring an additional 1,129 shares during the last quarter. Page Arthur B bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $1,026,000. Finally, Granite Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 1.4% during the 2nd quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock worth $8,397,000 after acquiring an additional 476 shares during the last quarter. 85.43% of the stock is owned by institutional investors.
A number of analysts have recently issued reports on the stock. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a report on Thursday, October 18th. Goldman Sachs Group reiterated a “buy” rating and issued a $277.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Piper Jaffray Companies lifted their target price on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 17th. Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. Finally, Raymond James lifted their target price on shares of UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, October 17th. One investment analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $289.41.
UNH stock opened at $276.55 on Friday. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $278.00. The stock has a market capitalization of $253.65 billion, a price-to-earnings ratio of 27.46, a PEG ratio of 1.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.75 and a current ratio of 0.69.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. During the same quarter in the previous year, the company earned $2.66 earnings per share. The company’s revenue for the quarter was up 12.4% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Inc will post 12.81 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.30%. UnitedHealth Group’s payout ratio is 35.75%.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Shares Sold by JNBA Financial Advisors” was originally posted by WKRB News and is the property of of WKRB News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.wkrb13.com/2018/11/10/unitedhealth-group-inc-unh-shares-sold-by-jnba-financial-advisors.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How is an ETF different from a mutual fund?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.